These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30496766)
21. EMP3 as a prognostic biomarker correlates with EMT in GBM. Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway. Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Lin JJ; Zhao TZ; Cai WK; Yang YX; Sun C; Zhang Z; Xu YQ; Chang T; Li ZY Oncotarget; 2015 Jul; 6(19):17107-20. PubMed ID: 25940798 [TBL] [Abstract][Full Text] [Related]
24. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Kahlert UD; Nikkhah G; Maciaczyk J Cancer Lett; 2013 May; 331(2):131-8. PubMed ID: 23268331 [TBL] [Abstract][Full Text] [Related]
25. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells. Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267 [TBL] [Abstract][Full Text] [Related]
26. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme. Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071 [TBL] [Abstract][Full Text] [Related]
27. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells. Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835 [TBL] [Abstract][Full Text] [Related]
28. Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas. Adamski V; Schmitt AD; Flüh C; Synowitz M; Hattermann K; Held-Feindt J Oncol Res; 2017 Mar; 25(3):341-353. PubMed ID: 27641619 [TBL] [Abstract][Full Text] [Related]
29. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma. Zhang XH; Qian Y; Li Z; Zhang NN; Xie YJ Oncol Rep; 2016 Nov; 36(5):2967-2975. PubMed ID: 27634309 [TBL] [Abstract][Full Text] [Related]
30. TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells. Tan Y; Hu X; Deng Y; Yuan P; Xie Y; Wang J Brain Res Bull; 2018 Oct; 143():138-144. PubMed ID: 30367895 [TBL] [Abstract][Full Text] [Related]
31. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma. Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308 [TBL] [Abstract][Full Text] [Related]
33. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells. Ouanouki A; Lamy S; Annabi B Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384 [TBL] [Abstract][Full Text] [Related]
34. Expression of Twist associated to microcirculation patterns of human glioma correlated with progression and survival of the patient. Li C; Chen Y; Zhang Q; Guo C; Chen F; Xi S; Zeng J; Ke C; Sharma HS; Chen Z Int Rev Neurobiol; 2020; 151():201-217. PubMed ID: 32448608 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Liu H; Lv Z; Guo E Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658 [TBL] [Abstract][Full Text] [Related]
36. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938 [TBL] [Abstract][Full Text] [Related]
38. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling. Song Y; Chen Y; Li Y; Lyu X; Cui J; Cheng Y; Zheng T; Zhao L; Zhao G Biomed Res Int; 2019; 2019():1321973. PubMed ID: 31119150 [TBL] [Abstract][Full Text] [Related]
39. Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA. Que Z; Zhou Z; Liu S; Zheng W; Lei B Biochem Biophys Res Commun; 2023 Oct; 675():130-138. PubMed ID: 37473527 [TBL] [Abstract][Full Text] [Related]
40. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation. Lu Y; Xiao L; Liu Y; Wang H; Li H; Zhou Q; Pan J; Lei B; Huang A; Qi S Autophagy; 2015; 11(12):2213-32. PubMed ID: 26553592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]